ArticlePharmacology research & perspectives2019

Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia.

Maiko Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.